Filter
192
Text search:
Community
Development
Medicinal
Unit
Featured
Recommendations
16
New Publications
61
Language
Document type
No document type
89
Studies & Reports
47
Guidelines
32
Manuals
11
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Countries / Regions
Kenya
11
Myanmar / Burma
9
India
7
Tanzania
7
Uganda
6
Ethiopia
5
Ghana
5
Zimbabwe
5
Nigeria
4
Nepal
4
South Africa
4
Bangladesh
4
Malawi
4
Rwanda
3
Indonesia
3
Botswana
3
Western and Central Europe
3
Global
3
Liberia
2
Cameroon
2
Philippines
2
Cambodia
2
Thailand
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
South–East Asia Region
2
Latin America and the Carribbean
2
Burkina Faso
1
Sierra Leone
1
Senegal
1
Haiti
1
Zambia
1
Mozambique
1
Peru
1
Brazil
1
Ukraine
1
Lesotho
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Asia
1
Africa
1
Fiji
1
Eastern Europe
1
Albania
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
99
Public Health
9
Clinical Guidelines
9
Pharmacy & Technologies
4
Women & Child Health
3
Key Resources
3
Capacity Building
1
Toolboxes
AMR
32
Pharmacy
24
COVID-19
12
HIV
10
Planetary Health
10
Rapid Response
5
Mental Health
5
TB
5
Global Health Education
3
Caregiver
2
NTDs
2
Disability
1
Ebola
1
Cholera
1
Zika
1
The report is based on comprehensive information collected at representative sample health facilities all over the country by well-organized and trained teams during May and August 2015. This is a continuation of 2014 Assessment activities and findings also reflect comparison between two consecutive
...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
